Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
Reviewers:
(1) Dhanya Dharman, Dr Moopens college of Pharmacy, India.
(2) Vijay Kumar Singh, Rani Durgawati Medical College, India.
(3) M.Noornissabegum, University of Madras, India.
(4) Ma. Cecilia O. Martinez RM,University of the City of Manila, Philippines.
Additional Reviewers:
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.87/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (Dhanya Dharman, India) | File 1 | NA
Stage 2 | Peer Review Report_2 (Vijay Kumar Singh, India) | File 1 | NA
Stage 2 | Peer Review Report_3 (M.Noornissabegum, India) | File 1 | NA
Stage 2 | Peer Review Report_4 (Ma. Cecilia O. Martinez RM, Philippines) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA